Attovia Therapeutics, Inc. ($ATTO)
Filing Information
| Accession Number | 0000905148-26-003548 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 10, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
39,474,221
Total Value
$6,499,984.00
P&L
+12.8% (+$833,527.36)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Aug 6, 2026 | Conversion | 2,311,870 | โ | โ | 2,311,870 | Direct | โ | View Details | |
10% Owner | Common Stock | โ | Aug 6, 2026 | Conversion | 821,998 | โ | โ | 3,133,868 | Direct | โ | View Details | |
10% Owner | Common Stock | โ | Aug 6, 2026 | Conversion | 665,147 | โ | โ | 3,799,015 | Direct | โ | View Details | |
10% Owner | Common Stock | โ | Aug 6, 2026 | Purchase | 382,352 | $17.00 | $6,499,984.00 | 4,181,367 | Direct | โ | View Details | |
10% Owner | Series A Preferred Stock | Derivative | Aug 6, 2026 | Conversion | 21,477,273 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
10% Owner | Series B Preferred Stock | Derivative | Aug 6, 2026 | Conversion | 7,636,362 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
10% Owner | Series C Preferred Stock | Derivative | Aug 6, 2026 | Conversion | 6,179,219 | $0.00 | $0.00 | 0 | Direct | โ | View Details |